reboxetine has been researched along with pentylenetetrazole in 2 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (pentylenetetrazole) | Trials (pentylenetetrazole) | Recent Studies (post-2010) (pentylenetetrazole) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 6,737 | 30 | 1,496 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahern, TH; Eagles, DA; Javors, MA; Liles, LC; Martillotti, J; Mitchell, HA; Weinshenker, D | 1 |
| Borowicz, KK; Popławska, M; Wróblewska, D | 1 |
2 other study(ies) available for reboxetine and pentylenetetrazole
| Article | Year |
|---|---|
The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Disease Models, Animal; Dopamine beta-Hydroxylase; Drug Administration Schedule; Electroshock; Flurothyl; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Reaction Time; Reboxetine; Seizures | 2006 |
Interactions between an antidepressant reboxetine and four classic antiepileptic drugs in the mouse model of myoclonic seizures.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Avoidance Learning; Clonazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Ethosuximide; Male; Mice; Morpholines; Motor Skills; Pentylenetetrazole; Phenobarbital; Reboxetine; Valproic Acid | 2015 |